CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $148.52 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-10
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $148.52M, a 5.16% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-30 was $140.82M, a 1.15% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $137.52M, a 3.50% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-07-01 was $139.73M, a 1.05% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $559.30M, a 1.56% increase from fiscal 2016.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $550.70M, a 9.04% increase from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $505.06M, a 1.03% increase from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $499.90M, a 4.94% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $148.52M 10-Q · filed 2018-05-10 | $289.33M derived: sum of 2 quarters · filed 2018-05-10 | $426.86M derived: sum of 3 quarters · filed 2018-05-10 | $566.59M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-30 | $140.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $278.34M derived: sum of 2 quarters · filed 2018-02-13 | $418.07M derived: sum of 3 quarters · filed 2018-02-13 | $559.30M 10-K · filed 2018-02-13 |
| 2017-09-30 | $137.52M 10-Q · filed 2017-11-09 | $277.25M derived: sum of 2 quarters · filed 2017-11-09 | $418.48M 10-Q · filed 2017-11-09 | $560.94M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-07-01 | $139.73M 10-Q · filed 2017-08-09 | $280.96M 10-Q · filed 2017-08-09 | $423.42M derived: sum of 3 quarters · filed 2018-05-10 | $556.29M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-04-01 | $141.23M 10-Q · filed 2018-05-10 | $283.69M derived: sum of 2 quarters · filed 2018-05-10 | $416.56M derived: sum of 3 quarters · filed 2018-05-10 | $557.76M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $142.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $275.32M derived: sum of 2 quarters · filed 2018-02-13 | $416.53M derived: sum of 3 quarters · filed 2018-02-13 | $550.70M 10-K · filed 2018-02-13 |
| 2016-09-24 | $132.87M 10-Q · filed 2017-11-09 | $274.08M derived: sum of 2 quarters · filed 2017-11-09 | $408.25M 10-Q · filed 2017-11-09 | $537.52M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-25 | $141.21M 10-Q · filed 2017-08-09 | $275.38M 10-Q · filed 2017-08-09 | $404.65M derived: sum of 3 quarters · filed 2018-02-13 | $531.61M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-26 | $134.17M 10-Q · filed 2017-05-10 | $263.44M derived: sum of 2 quarters · filed 2018-02-13 | $390.40M derived: sum of 3 quarters · filed 2018-02-13 | $515.59M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-26 | $129.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $256.23M derived: sum of 2 quarters · filed 2018-02-13 | $381.42M derived: sum of 3 quarters · filed 2018-02-13 | $505.06M 10-K · filed 2018-02-13 |
| 2015-09-26 | $126.96M 10-Q · filed 2016-11-02 | $252.15M derived: sum of 2 quarters · filed 2016-11-02 | $375.79M 10-Q · filed 2016-11-02 | $495.67M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-27 | $125.19M 10-Q · filed 2016-08-03 | $248.83M 10-Q · filed 2016-08-03 | $368.71M derived: sum of 3 quarters · filed 2017-02-14 | $491.52M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-28 | $123.63M 10-Q · filed 2016-05-04 | $243.52M derived: sum of 2 quarters · filed 2017-02-14 | $366.33M derived: sum of 3 quarters · filed 2017-02-14 | $496.51M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-27 | $119.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $242.70M derived: sum of 2 quarters · filed 2017-02-14 | $372.87M derived: sum of 3 quarters · filed 2017-02-14 | $499.90M 10-K · filed 2017-02-14 |
| 2014-09-27 | $122.82M 10-Q · filed 2015-11-04 | $252.99M derived: sum of 2 quarters · filed 2015-11-04 | $380.01M 10-Q · filed 2015-11-04 | $491.50M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-28 | $130.18M 10-Q · filed 2015-07-30 | $257.20M 10-Q · filed 2015-07-30 | $368.68M derived: sum of 3 quarters · filed 2016-02-12 | $485.42M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-29 | $127.02M 10-Q · filed 2015-04-30 | $238.51M derived: sum of 2 quarters · filed 2016-02-12 | $355.24M derived: sum of 3 quarters · filed 2016-02-12 | $477.10M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-28 | $111.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $228.22M derived: sum of 2 quarters · filed 2016-02-12 | $350.07M derived: sum of 3 quarters · filed 2016-02-12 | $476.36M 10-K · filed 2016-02-12 |
| 2013-09-28 | $116.73M 10-Q · filed 2014-10-30 | $238.59M derived: sum of 2 quarters · filed 2014-10-30 | $364.88M 10-Q · filed 2014-10-30 | $476.29M derived: sum of 4 quarters · filed 2014-10-30 |
| 2013-06-29 | $121.86M 10-Q · filed 2014-08-07 | $248.15M 10-Q · filed 2014-08-07 | $359.55M derived: sum of 3 quarters · filed 2014-08-07 | $470.75M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-30 | $126.29M 10-Q · filed 2014-04-30 | $237.70M derived: sum of 2 quarters · filed 2014-04-30 | $348.89M derived: sum of 3 quarters · filed 2014-04-30 | $468.02M derived: sum of 4 quarters · filed 2014-04-30 |
| 2012-12-29 | $111.41M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $222.60M derived: sum of 2 quarters · filed 2014-02-25 | $341.73M derived: sum of 3 quarters · filed 2014-02-25 | $467.94M 10-K · filed 2014-02-25 |
| 2012-09-29 | $111.20M 10-Q · filed 2013-10-30 | $230.32M derived: sum of 2 quarters · filed 2013-10-30 | $356.54M 10-Q · filed 2013-10-30 | $478.77M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $119.13M 10-Q · filed 2013-07-31 | $245.34M 10-Q · filed 2013-07-31 | $367.58M derived: sum of 3 quarters · filed 2014-02-25 | $484.51M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $126.21M 10-Q · filed 2013-05-08 | $248.45M derived: sum of 2 quarters · filed 2014-02-25 | $365.39M derived: sum of 3 quarters · filed 2014-02-25 | $488.13M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $122.24M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $239.17M derived: sum of 2 quarters · filed 2014-02-25 | $361.91M derived: sum of 3 quarters · filed 2014-02-25 | $483.31M 10-K · filed 2014-02-25 |
| 2011-09-24 | $116.93M 10-Q · filed 2012-11-01 | $239.67M derived: sum of 2 quarters · filed 2012-11-01 | $361.07M 10-Q · filed 2012-11-01 | $474.62M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | $122.74M 10-Q · filed 2012-08-07 | $244.14M 10-Q · filed 2012-08-07 | $357.69M derived: sum of 3 quarters · filed 2013-02-27 | $466.38M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | $121.40M 10-Q · filed 2012-05-04 | $234.95M derived: sum of 2 quarters · filed 2013-02-27 | $343.63M derived: sum of 3 quarters · filed 2013-02-27 | $458.97M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-25 | $113.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $222.24M derived: sum of 2 quarters · filed 2013-02-27 | $337.57M derived: sum of 3 quarters · filed 2013-02-27 | $458.62M 10-K · filed 2013-02-27 |
| 2010-09-25 | $108.68M 10-Q · filed 2011-11-02 | $224.02M derived: sum of 2 quarters · filed 2011-11-02 | $345.07M 10-Q · filed 2011-11-02 | $461.51M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-26 | $115.33M 10-Q · filed 2011-08-03 | $236.38M 10-Q · filed 2011-08-03 | $352.82M derived: sum of 3 quarters · filed 2012-02-27 | $466.27M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-27 | $121.05M 10-Q · filed 2011-05-04 | $237.49M derived: sum of 2 quarters · filed 2012-02-27 | $350.94M derived: sum of 3 quarters · filed 2012-02-27 | $469.41M derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-26 | $116.44M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $229.88M derived: sum of 2 quarters · filed 2012-02-27 | $348.36M derived: sum of 3 quarters · filed 2012-02-27 | $465.27M 10-K · filed 2012-02-27 |
| 2009-09-26 | $113.44M 10-Q · filed 2010-11-04 | $231.92M derived: sum of 2 quarters · filed 2010-11-04 | $348.83M 10-Q · filed 2010-11-04 | |
| 2009-06-27 | $118.47M 10-Q · filed 2010-08-03 | $235.38M 10-Q · filed 2010-08-03 | ||
| 2008-12-27 | $471.74M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |